MedPath
NMPA Approval

Dapagliflozin Tablets

国药准字H20234134

September 12, 2023

Drug Information

达格列净片

片剂

10mg(以C₂₁H₂₅ClO₆计)

化学药品

September 12, 2023

Company Information

Applicant Company

眉山经济开发区新区

Manufacturing Company

眉山市经济开发区新区

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.

达格列净片 - NMPA 批准文号 | MedPath